中文产业新闻评分64Chinese source
恒瑞医药每周口服GLP-1 HRS-1596以3亿美元授权诺和诺德海外权益
3亿美金出海！每周口服GLP‑1，HRS‑1596能否挑战替尔泊肽？
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
3亿美金出海！每周口服GLP‑1，HRS‑1596能否挑战替尔泊肽？
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.